LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Coin-Sized POC Device Detects Measles Virus in Saliva

By LabMedica International staff writers
Posted on 08 Jul 2022
Print article
Image: Novel POC biosensing device can detect measles virions in human saliva (Photo courtesy of Pexels)
Image: Novel POC biosensing device can detect measles virions in human saliva (Photo courtesy of Pexels)

Measles is one of the most infectious airborne viruses worldwide. With a basic reproduction rate of between 12-18, this virus is six times more infectious than the SARS-CoV-2 Alpha variant and similar to the SARS-CoV-2 Omicron variant. Even though a cheap and effective vaccine is available, measles is still common in developing countries. To date, sporadic outbreaks are also reported in developed countries, primarily due to non-vaccinated people. Now, a new point-of-care (POC) biosensing device that is capable of detecting measles virions (MV) in human saliva may help with efforts to control the viral spread.

The device developed by researchers at the Nanoscience Institute of the Italian National Research Council (Rome, Italy) is a surface-acoustic-wave (SAW) based lab-on-a-chip (LOC), smaller than a €1-cent coin, in which SAWs are used both for sensing and fluid recirculation. Experiments have validated the accuracy of the lab-on-a-chip device which may offer a convenient platform for measles diagnosis and serve as a guideline for designing new microfluidic biosensing systems.

“Our technology for the first time demonstrated the synergic operation of different surface-acoustic-wave-based micro devices on the same chip, in the context of lab-on-a-chip biosensing. In this way we have been able to drastically improve the detection limit of our sensors, potentially enabling early point-of-care diagnostic applications,” said senior author Marco Cecchini, PhD, Senior Researcher of the Nanoscience Institute of the Italian National Research Council.

Related Links:
Italian National Research Council

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more